Showing 271-280 of 300 results for "".
A Cataract Surgeon and the Referral Network: A Roundtable Discussion
https://modernod.com/topics/cataractrefractive-surgery/a-cataract-surgeon-and-the-referral-network-a-roundtable-discussion/39196/A cataract surgeon sits down with his referral network to discuss the nuances of cataract collaboration.The Persistent Problem of Dysphotopsias
https://modernod.com/topics/cataractrefractive-surgery/the-persistent-problem-of-dysphotopsias/39192/What does research tell us about this source of frustration for cataract surgeons and affected patients?Avoiding the Appearance of Kickback Arrangements in OD/MD Relationships
https://modernod.com/topics/cataractrefractive-surgery/avoiding-the-appearance-of-kickback-arrangements-in-od-md-relationships/39184/An overview of fraud and abuse issues with respect to relationships between independent optometrists and ophthalmologists.Three Questions to Ask About ROI When Purchasing Diagnostics
https://modernod.com/topics/business/three-questions-to-ask-about-roi-when-purchasing-diagnostics/39176/Do you really need that new equipment?DREAM Interpretations Abound Following Surprising Dry Eye Study Findings
https://modernod.com/topics/ocular-surface/dream-interpretations-abound-following-surprising-dry-eye-study-findings/39173/Control and placebo groups in DREAM both achieved similar improvements in OSDI scores; study authors concluded that omega-3 supplements were no better than the refined olive oil placebo.OD-OD Relationships: A Surgical Story
https://modernod.com/topics/cataractrefractive-surgery/od-od-relationships-a-surgical-story/39155/col·lab·o·rate — to work jointly with others or together especially in an intellectual endeavorA (Very) Brief History of IOLs
https://modernod.com/topics/cataractrefractive-surgery/a-very-brief-history-of-iols/39145/Premium implant technologies can address a range of issues, with increasing emphasis on customization.- Belite Bio’s Tinlarebant Studied to Treat Childhood-onset Stargardt Diseasehttps://modernod.com/news/belite-bios-tinlarebant-studied-to-treat-childhood-onset-stargardt-disease/2481950/Belite Bio presented final data from a 24-month, phase 2 study of Tinlarebant (LBS-008) in adolescent Stargardt disease (STGD1). The study—LBS-008-CT02—enrolled 12 adolescent STGD1 patients, aged 12-18 years, who completed
- Nearly Half of Physicians Believe It Will Take a Year to Get COVID-19 Under Controlhttps://modernod.com/news/nearly-half-of-physicians-believe-it-will-take-a-year-to-get-covid-19-under-control/2478174/The majority of physicians believe COVID-19 won’t be under control until January 2021, and nearly half (49%) expect it will take much longer to get the virus under control, according to a FierceHealthcare
- Study: Pediatric Keratoconus Prevalence Higher than Believed; May Change Care Approachhttps://modernod.com/news/study-pediatric-keratoconus-prevalence-higher-than-believed-may-change-care-approach/2482171/A new study, published in the journal Eye and Contact Lens, found that by utilizing Scheimpflug tomography during a comprehensive eye examination clinicians identified keratoconus in a limited pediatric population at a far gre